Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy

Journal of the American Veterinary Medical Association

Volumn 232, Issue 6, 2008, Pages 867-872

  Bailey, Kerry Smith ^a,d   Dewey, Curtis W ^a,d   Boothe, Dawn M ^b   Barone, Georgina ^a   Kortz, Gregg D ^c  

^a Long Island Veterinary Specialists ^*  (United States)

^b AUBURN UNIVERSITY   (United States)

^c California Veterinary Neurology and Neurosurgery Specialists   (United States)

^d Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DRUG DERIVATIVE; ETIRACETAM; PHENOBARBITAL; PIRACETAM;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; DRUG COMBINATION; EPILEPSY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HALF LIFE TIME; MALE; TREATMENT OUTCOME;

ANIMALS; ANTICONVULSANTS; CAT DISEASES; CATS; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; EPILEPSY; EPILEPSY, GENERALIZED; FEMALE; HALF-LIFE; MALE; PHENOBARBITAL; PIRACETAM; TREATMENT OUTCOME;

ANIMALIA;

EID: 41549131763     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.232.6.867     Document Type: Article

References (24)

1. Thomas WB. Seizures and narcolepsy. In: Dewey CW, ed. A practical guide to canine and feline neurology. Ames, Iowa: Iowa State Press, 2003;193-212.
2. Dewey CW. Anticonvulsant therapy in dogs and cats. Vet Clin North Am Small Anim Pract 2006;36:1107-1127.
3. Cochrane SM, Parent JM, Black WD, et al. Pharmacokinetics of phenobarbital in the cat following multiple oral administration. Can J Vet Res 1990;54:309-312.
4. Dayrell-Hart B, Steinberg SA, VanWinkle RJ, et al. Hepatotoxicity of phenobarbital in dogs: 18 cases (1985-1989). J Am Vet Med Assoc 1991;199:1060-1066.
5. Gaskill CL, Miller LM, Mattoon JS, et al. Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital. Vet Pathol 2005;42:147-160.
6. Ducote JM, Coates JR, Dewey CW, et al. Suspected hypersensitivity to phenobarbital in a cat. J Feline Med Surg 1999; 1:123-126.
7. Quesnel AD, Parent JM, McDonell W. Clinical management and outcome of cats with seizure disorders: 30 cases (1991-1993). J Am Vet Med Assoc 1997;210:72-77.
8. Boothe DM. Anticonvulsant therapy in small animals. Vet Clin North Am Small Anim Pract 1998;28:411-447.
9. Center SA, Elston TH, Rowland PH, et al. Fulminant hepatic failure associated with oral administration of diazepam in 11 cats. J Am Vet Med Assoc 1996;209:618-625.
10. Hughes D, Moreau RE, Overall KL, et al. Acute hepatic necrosis and liver failure associated with benzodiazepine therapy in six cats. J Vet Emerg Crit Care 1996;6:13-20.
11. Boothe DM, George KL, Couch P. Disposition and clinical use of bromide in cats. J Am Vet Med Assoc 2002;221:1131-1135.
12. Klitgaard H, Matagne A, Gobert J, et al. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 1998;353:191-206.
13. Hovinga CA. Levetiracetam: a novel antiepileptic drug. Pharmacotherapy 2001;21:1375-1388.
14. Leppik IE. The place of levetiracetam in the treatment of epilepsy. Epilepsia 2001;42(suppl 4):44-45.
15. Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 2000;85:77-85.
16. Isoherranen N, Yagen B, Soback S, et al. Pharmacokinetics of levetiracetam and its enantiomer (R)-α-ethyl-2-oxo-pyrrolidine acetamide in dogs. Epilepsia 2001;42:825-830.
17. Briggs DE, French JA. Levetiracetam safety profiles and tolerability in epilepsy patients. Expert Opin Drug Saf 2004;3: 415-424.
18. Nicolas JM, Collart P, Gerin B, et al. In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent. Drug Metab Dispos 1999;27:250-254.
19. Kinirons P, McCarthy M, Doherty CP, et al. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam. Seizure 2006;15:387-392.
20. Volk HA, Matiasek LA, Feliu-Pascual AL, et al. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs. Vet J 2007;in press, doi: 10.1016/j.tyjl.2007.03.002. Accessed Jan 24, 2008.
21. Pucci V, Bugamelli F, Roberto M, et al. High-performance liquid chromatographic determination of levetiracetam in human plasma: comparison of different sample clean-up procedures. Biomed Chromatogr 2004;18:37-44.
22. Ratnaraj N, Doheny HC, Patsalos PN. A micromethod for the determination of the new antiepileptic drug levetiracetam (ucb L059) in serum or plasma by high performance liquid chromatography. Ther Drug Monit 1996;18:154-157.
23. Bazil CW New antiepileptic drugs. Neurologist 2002;8:71-81.
24. Shorvon SD, van Rijckevorsel K. A new antiepileptic drug. J Neurol Neurosurg Psychiatry 2002;72:426-429.